OB/GYN Clinical Alert – January 1, 2011
January 1, 2011
View Issues
-
Postplacental Insertion of Levonorgestrel-releasing IUS
The authors enrolled women desiring postpartum use of a levonorgestrel-releasing intrauterine system in a randomized trial to determine whether use of the device would be higher when insertion occurred immediately postpartum rather than delaying placement to the standard postpartum visit. -
Intrapartum Tests for Group B Streptococcus
The rate of sepsis with group b streptococcus (gbs) in neonates of colonized mothers is now less than 1%. -
Tranexamic Acid Reduces Menstrual Blood Loss
The authors randomized women with objectively validated heavy menstrual bleeding (mean menstrual blood loss [MBL] of 80 mL or more per cycle, confirmed using the alkaline hematin methodology during two pretreatment cycles) to treatment with oral tranexamic acid 3.9 g/d or placebo for up to 5 days per cycle for 6 menstrual cycles. -
Special Feature: Primary Ovarian Surgical Cytoreduction: When? How Much? Why?
Nearly every reference source discussing the primary management of advanced ovarian cancer will highlight the role of surgical cytoreduction as an important first step in the care of this disease. -
Pharmacology Watch: Rivaroxaban: Another Warfarin Replacement
In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions. -
Clinical Briefs in Primary Care supplement